Research Library

144 papers referenced across protocols, genetics, and bloodwork. Evidence-tiered with AI summaries.

Source:

144 papers

Frontiers: Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
FrontiersPreclinical (Animal)Source ↗
PQK7 Peptide - ScienceDirect
ScienceDirect2026Review/CommentarySource ↗
Intranasal Peptide Therapeutics - MDPI
MDPI2026Review/CommentarySource ↗
Intranasal Drug Delivery for CNS - PMC
PMC2026Review/CommentarySource ↗
Mitochondrial Microproteins - PMC
PMC2026Review/CommentarySource ↗
Humanin Intranasal Delivery - PMC
PMC2026Preclinical (Animal)Source ↗
Angiotensin IV Analogs - ScienceDirect
ScienceDirect2026Review/CommentarySource ↗
SS-31 Mitochondrial Mechanisms - ScienceDirect
ScienceDirect2026Review/CommentarySource ↗
Semax BDNF Study - ScienceDirect
ScienceDirect2026Preclinical (Animal)Source ↗
GLP-1 Agonist Meta-Analysis - PMC
PMC2026Meta-analysis/Systematic ReviewSource ↗
Semaglutide in Animal Models - PMC
PMC2026Review/CommentarySource ↗
Microbes and Parkinson's disease: from associations to mechanisms
ScienceDirect2026Review/CommentarySource ↗
Hospital-treated infectious diseases, infection burden and risk of Parkinson disease
ScienceDirect2026Cohort StudySource ↗
Bacterial, viral, and fungal infection‐related risk of Parkinson's disease: Meta‐analysis - PMC
PMC2026Meta-analysis/Systematic ReviewSource ↗
Can infections trigger alpha-synucleinopathies? - PMC
PMC2026Review/CommentarySource ↗
The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses
MDPI2026Review/CommentarySource ↗
Genetic Underpinnings of Host Manipulation by Ophiocordyceps as Revealed by Comparative Transcriptomics - PMC
PMC2026In Vitro/Cell LineSource ↗
The metabolic alteration and apparent preservation of the zombie ant brain
ScienceDirect2026Preclinical (Animal)Source ↗
Unique Bioactives from Zombie Fungus (Cordyceps) as Promising Multitargeted Neuroprotective Agents
MDPI2026Review/CommentarySource ↗
Fungal β-Glucans: Biological Properties, Immunomodulatory Effects, Diagnostic and Therapeutic Applications - PMC
PMC2026Review/CommentarySource ↗
Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential - PMC
PMC2026Review/CommentarySource ↗
Microbiota Orchestra in Parkinson's Disease: The Nasal and Oral Maestros
MDPI2026Review/CommentarySource ↗
Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review - PMC
PMC2026Review/CommentarySource ↗
The microbiome–nose–brain axis in health and disease
ScienceDirect2026Review/CommentarySource ↗
Functional characterization of alpha-synuclein protein with antimicrobial activity
ScienceDirect2026In Vitro/Cell LineSource ↗
Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease - PMC
PMC2026Review/CommentarySource ↗
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
ScienceDirect2026Review/CommentarySource ↗
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
PMC2026Preclinical (Animal)Source ↗
Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons
ScienceDirect2026Review/CommentarySource ↗
Parkinson's gut-microbiota links raise treatment possibilities
Nature2026Review/CommentarySource ↗
From Mitochondrial Function to Neuroprotection – An Emerging Role for Methylene Blue - PMC
PMC2026Review/CommentarySource ↗
Repurposing niclosamide for the treatment of neurological disorders - PMC
PMC2026Review/CommentarySource ↗
Malassezia and Parkinson's Disease - PMC
PMC2026Cohort StudySource ↗
Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue - PMC
PMC2026Case Report/SeriesSource ↗
PMC: PMC4176007
PMC2026Cohort StudySource ↗
PMC: PMC12755871
PMC2026Review/CommentarySource ↗
PMC: PMC11498467
PMC2026Review/CommentarySource ↗
ScienceDirect
ScienceDirect2026Review/CommentarySource ↗
ResearchGate
ResearchGate2026Review/CommentarySource ↗
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
PMC2026Review/CommentarySource ↗
MDPI Pharmaceuticals
MDPI2026Review/CommentarySource ↗
PubMed Central (PMC)
PMC2026Review/CommentarySource ↗
PubMed/MEDLINE
PubMed2026Review/CommentarySource ↗
Preclinical safety evaluation of body-protective compound-157
ScienceDirect2026Preclinical (Animal)Source ↗
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157
PMC2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157 and NO-System
Springer2026Review/CommentarySource ↗
Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway
PMC2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
MDPI2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma
PMC2026Preclinical (Animal)Source ↗
ResearchGate publication
ResearchGate2026Review/CommentarySource ↗
The anti-nociceptive effect of BPC-157 on the incisional pain model in rats
PMC2026Preclinical (Animal)Source ↗
Robert's Intragastric Alcohol-Induced Gastric Lesion Model
MDPI2026Review/CommentarySource ↗
BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias
ScienceDirect2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction
PMC2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in Heart Disturbances
PMC2026Preclinical (Animal)Source ↗
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
MDPI2026Review/CommentarySource ↗
Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury
ScienceDirect2026Preclinical (Animal)Source ↗
Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury
PMC2026Preclinical (Animal)Source ↗
Pentadecapeptide BPC 157 and the central nervous system
PMC2026Review/CommentarySource ↗
A novel pentadecapeptide BPC 157 blocks the stereotypy produced acutely by amphetamine
ScienceDirect2026Preclinical (Animal)Source ↗
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances
ResearchGate2026Preclinical (Animal)Source ↗
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
PMC2026Review/CommentarySource ↗
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
PMC2026Review/CommentarySource ↗
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
PMC2026In Vitro/Cell LineSource ↗
Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats
MDPI2026Preclinical (Animal)Source ↗
Pentadecapeptide BPC 157 effective in healing of colocutaneous fistulas in rats
ScienceDirect2026Preclinical (Animal)Source ↗
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis
PMC2026Review/CommentarySource ↗
Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection
PMC2026Review/CommentarySource ↗
VIP Neuroprotection 2025 - PubMed
PubMed2025Review/CommentarySource ↗
Intranasal Nanoemulsions 2025 - PubMed
PubMed2025Review/CommentarySource ↗
MDPs in Neurodegeneration - Springer
Springer2025Review/CommentarySource ↗
Elamipretide Review 2025 - PMC
PMC2025Review/CommentarySource ↗
Trained immunity: induction of an inflammatory memory in disease
Nature2025Review/CommentarySource ↗
Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential
Frontiers2025Review/CommentarySource ↗
Nasal microbiome in relation to olfactory dysfunction and cognitive decline in older adults
Nature2025Cohort StudySource ↗
Exploring the role of gut microbiota in Parkinson's disease: insights from fecal microbiota transplantation
Frontiers2025Review/CommentarySource ↗
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key (MDPI 2025)
MDPI2025Review/CommentarySource ↗
Response to rebuttal: Sikiric defense of BPC-157 safety profile
PMC2025Review/CommentarySource ↗
Rebuttal: disputes Sikiric anti-tumor claims for BPC-157
PMC2025Review/CommentarySource ↗
Body Protective Compound-157: A systematic review of preclinical and clinical evidence
PMC2025Meta-analysis/Systematic ReviewSource ↗
BPC-157 intravenous safety pilot
PubMed2025Case Report/SeriesSource ↗
Prasinezumab Sustained Effect - Nature Medicine
Nature2024Randomized Controlled TrialSource ↗
CDNF AAV Gene Therapy - Nature
Nature2024Preclinical (Animal)Source ↗
Exploring pathological link between antimicrobial and amyloid peptides
PubMed2024Review/CommentarySource ↗
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Nature2024Review/CommentarySource ↗
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update - PMC
PMC2024Review/CommentarySource ↗
Potent induction of trained immunity by Saccharomyces cerevisiae β-glucans
Frontiers2024Preclinical (Animal)Source ↗
Frontiers in Immunology
Frontiers2024Review/CommentarySource ↗
BPC-157 for interstitial cystitis: pilot study
PubMed2024Case Report/SeriesSource ↗
MOTS-c Review - Frontiers
Frontiers2023Review/CommentarySource ↗
NR-SAFE Trial - Nature Communications
Nature2023Randomized Controlled TrialSource ↗
CDNF/MANF Review - PubMed
PubMed2023Review/CommentarySource ↗
CDNF Phase 1 Trial - PubMed
PubMed2023Randomized Controlled TrialSource ↗
Increased diversity of Malassezia species on the skin of Parkinson's disease patients
Frontiers2023Case Report/SeriesSource ↗
Exercise-induced skeletal muscle angiogenesis: a review of signaling pathways
PMC2023Review/CommentarySource ↗
Amyloid peptides with antimicrobial and/or microbial agglutination activity
Springer2022Review/CommentarySource ↗
Frontiers Pharmacology: Pharmacokinetics, distribution, metabolism, and excretion
Frontiers2022Preclinical (Animal)Source ↗
PMID: 36359218
PubMed2022Review/CommentarySource ↗
BDNF in PD - Nature
Nature2021Review/CommentarySource ↗
Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease
Nature2021Case Report/SeriesSource ↗
PMID: 34201112
PubMed2021Preclinical (Animal)Source ↗
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
Frontiers2021Preclinical (Animal)Source ↗
Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy
PubMed2021Preclinical (Animal)Source ↗
BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability
PubMed2021Review/CommentarySource ↗
BPC-157 for knee pain: retrospective chart review
PubMed2021Case Report/SeriesSource ↗
Metformin: the next angiogenesis panacea?
PMC2021Review/CommentarySource ↗
Semaglutide Neuroprotection Study - PubMed
PubMed2020Preclinical (Animal)Source ↗
Nature Scientific Reports independent verification
Nature2020In Vitro/Cell LineSource ↗
Metabolic regulation of exercise-induced angiogenesis
PMC2020Review/CommentarySource ↗
Malassezia and Parkinson's Disease
Frontiers2019Review/CommentarySource ↗
Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits - PubMed
PubMed2019Preclinical (Animal)Source ↗
PMID: 29798983
PubMed2019Randomized Controlled TrialSource ↗
Journal of Orthopaedic Surgery and Research
Springer2019Preclinical (Animal)Source ↗
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
PubMed2019Review/CommentarySource ↗
BPC 157 and Standard Angiogenic Growth Factors
PubMed2019Review/CommentarySource ↗
Daily consumption of methylene blue reduces attentional deficits and dopamine reduction in a 6-OHDA model of Parkinson's disease - PubMed
PubMed2018Preclinical (Animal)Source ↗
Dihexa Development - PubMed
PubMed2015Review/CommentarySource ↗
Stable gastric pentadecapeptide BPC 157-NO-system relation
PubMed2015Review/CommentarySource ↗
Perforating corneal injury in rat and pentadecapeptide BPC 157
PubMed2015Preclinical (Animal)Source ↗
Dihexa HGF/c-Met Mechanism - PubMed
PubMed2014Preclinical (Animal)Source ↗
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
PubMed2012Review/CommentarySource ↗
Vitamin D improves angiogenic properties of endothelial progenitor cells
PMC2012Preclinical (Animal)Source ↗
The promoting effect of pentadecapeptide BPC 157 on tendon healing
PubMed2011In Vitro/Cell LineSource ↗
PMID: 21295044
PubMed2011Preclinical (Animal)Source ↗
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
PubMed2011Review/CommentarySource ↗
PMID: 19662538
PubMed2010Preclinical (Animal)Source ↗
Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice
PubMed2010Preclinical (Animal)Source ↗
Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat
PubMed2010Preclinical (Animal)Source ↗
Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats
PubMed2009Preclinical (Animal)Source ↗
PMID: 18204410
PubMed2008Review/CommentarySource ↗
PMID: 18756821
PubMed2008Preclinical (Animal)Source ↗
PMID: 16996037
PubMed2007Preclinical (Animal)Source ↗
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease heals ileoileal anastomosis
PubMed2007Preclinical (Animal)Source ↗
Genes that distinguish physiological and pathological angiogenesis
PMC2007Review/CommentarySource ↗
Chronic polysystemic candidiasis as a possible contributor to onset of idiopathic Parkinson's disease - PubMed
PubMed2006Review/CommentarySource ↗
PMID: 15678666
PubMed2005Preclinical (Animal)Source ↗
Gastric pentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats
PubMed2005Preclinical (Animal)Source ↗
PMID: 15088389
PubMed2004Preclinical (Animal)Source ↗
BPC-157 PD Study - PubMed
PubMed2000Preclinical (Animal)Source ↗
The antidepressant effect of an antiulcer pentadecapeptide BPC 157
PubMed2000Preclinical (Animal)Source ↗
Osteogenic effect of gastric pentadecapeptide BPC-157 on segmental bone defect in rabbits
PubMed1999Preclinical (Animal)Source ↗
The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain
Springer1993Preclinical (Animal)Source ↗
Hepatoprotective effect of BPC 157
PubMed1993Preclinical (Animal)Source ↗
Antiulcer activities of BPC-157 (PL-10, PLD-116), a novel gastric pentadecapeptide
PubMed1993Preclinical (Animal)Source ↗